This episode features Dr. Anna Casu, Associate Investigator at Translational Research Institute - AdventHealth. Here, she shares more information about the work AdventHealth is doing with TZIELD, the first FDA approved drug that can delay the progression of Type 1 diabetes, her own personal journey being diagnosed with Type 1 diabetes herself, and more.

• Dr. Casu does not administer the treatment herself.